Yamamoto N - Search Results

1

Natural killer cells in breast cancer cell growth and metastasis in SCID mice.

Dewan MZ, Terunuma H, Ahmed S, Ohba K, Takada M, Tanaka Y, Toi M, Yamamoto N. Dewan MZ, et al. Among authors: yamamoto n. Biomed Pharmacother. 2005 Oct;59 Suppl 2:S375-9. doi: 10.1016/s0753-3322(05)80082-4. Biomed Pharmacother. 2005. PMID: 16507413 Review.

2

OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.

Takahashi Y, Tanaka Y, Yamashita A, Koyanagi Y, Nakamura M, Yamamoto N. Takahashi Y, et al. Among authors: yamamoto n. J Virol. 2001 Aug;75(15):6748-57. doi: 10.1128/JVI.75.15.6748-6757.2001. J Virol. 2001. PMID: 11435553 Free PMC article.

3

Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.

Dewan MZ, Ahmed S, Iwasaki Y, Ohba K, Toi M, Yamamoto N. Dewan MZ, et al. Among authors: yamamoto n. Biomed Pharmacother. 2006 Jul;60(6):273-6. doi: 10.1016/j.biopha.2006.06.004. Epub 2006 Jun 28. Biomed Pharmacother. 2006. PMID: 16828253 Review.

4

Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.

Yamamoto N, Imai J, Watanabe M, Hiroi N, Sugano S, Yoshino G. Yamamoto N, et al. Horm Metab Res. 2006 Mar;38(3):159-66. doi: 10.1055/s-2006-925185. Horm Metab Res. 2006. PMID: 16673206

5

Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.

Nishi M, Sakai Y, Akutsu H, Nagashima Y, Quinn G, Masui S, Kimura H, Perrem K, Umezawa A, Yamamoto N, Lee SW, Ryo A. Nishi M, et al. Among authors: yamamoto n. Oncogene. 2014 Jan 30;33(5):643-52. doi: 10.1038/onc.2012.614. Epub 2013 Jan 14. Oncogene. 2014. PMID: 23318426 Free PMC article.

6

Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells.

Nakamura N, Fujii M, Tsukahara T, Arai M, Ohashi T, Wakao H, Kannagi M, Yamamoto N. Nakamura N, et al. Among authors: yamamoto n. Oncogene. 1999 Apr 29;18(17):2667-75. doi: 10.1038/sj.onc.1202608. Oncogene. 1999. PMID: 10348340

7

High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection.

Koyanagi Y, Tanaka Y, Tanaka R, Misawa N, Kawano Y, Tanaka T, Miyasaka M, Ito M, Ueyama Y, Yamamoto N. Koyanagi Y, et al. Among authors: yamamoto n. Leukemia. 1997 Apr;11 Suppl 3:109-12. Leukemia. 1997. PMID: 9209314

8

Binding of HIV-2 envelope glycoprotein to CD8 molecules and related chemokine production.

Akimoto H, Kaneko H, Sekigawa I, Hashimoto H, Kaneko Y, Yamamoto N. Akimoto H, et al. Among authors: yamamoto n. Immunology. 1998 Oct;95(2):214-8. doi: 10.1046/j.1365-2567.1998.00537.x. Immunology. 1998. PMID: 9824478 Free PMC article.

9

Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas.

Tanaka K, Kondoh N, Shuda M, Matsubara O, Imazeki N, Ryo A, Wakatsuki T, Hada A, Goseki N, Igari T, Hatsuse K, Aihara T, Horiuchi S, Yamamoto N, Yamamoto M. Tanaka K, et al. Among authors: yamamoto n, yamamoto m. Biochim Biophys Acta. 2001 Apr 30;1536(1):1-12. doi: 10.1016/s0925-4439(01)00026-6. Biochim Biophys Acta. 2001. PMID: 11335099

10

Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120.

Sekigawa I, Koshino K, Hishikawa T, Kaneko H, Takasaki Y, Hashimoto H, Hirose S, Inagaki Y, Yamamoto N. Sekigawa I, et al. Among authors: yamamoto n. J Clin Immunol. 1995 Nov;15(6):312-7. doi: 10.1007/BF01541321. J Clin Immunol. 1995. PMID: 8576317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results